Recently, the roles of follicle-stimulating hormone (FSH) in metabolic diseases (obesity, dyslipidemia, metabolic syndrome, diabetes, and atherosclerotic cardiovascular disease), which are closely related to NAFLD, have been gradually revealed [10–13]. The gene discussed is BRD2; the disease is metabolic disease.